... breakthrough in HCV treatment. Gilead has 15 FDA approved drugs already on the market with indications for HIV/AIDS, liver disease, cardiovascular disease, respiratory ailments, and more. The company also has an extensive pipeline of compounds in ...
http://seekingalpha.com/article/1860921-4-biotech-stocks-with-upcoming-fda-decision-dates?source=feed
http://seekingalpha.com/article/1860921-4-biotech-stocks-with-upcoming-fda-decision-dates?source=feed
No comments:
Post a Comment